UI022 or UI023 and co-administration of matching placebo
KUP-UI022-301
Phase 3 small_molecule completed
Quick answer
UI022 or UI023 and co-administration of matching placebo for Peripheral Arterial Disease is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Peripheral Arterial Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed